169 related articles for article (PubMed ID: 14528077)
1. Renal medullary carcinoma: case report and review of the literature.
Noguera-Irizarry WG; Hibshoosh H; Papadopoulos KP
Am J Clin Oncol; 2003 Oct; 26(5):489-92. PubMed ID: 14528077
[TBL] [Abstract][Full Text] [Related]
2. High-dose-intensity MVAC for Advanced Renal Medullary Carcinoma: Report of Three Cases and Literature Review.
Rathmell WK; Monk JP
Urology; 2008 Sep; 72(3):659-63. PubMed ID: 18649931
[TBL] [Abstract][Full Text] [Related]
3. Prolonged survival of a patient with sickle cell trait and metastatic renal medullary carcinoma.
Pirich LM; Chou P; Walterhouse DO
J Pediatr Hematol Oncol; 1999; 21(1):67-9. PubMed ID: 10029817
[TBL] [Abstract][Full Text] [Related]
4. [Renal pelvic tumor in chronic renal failure: report of a case].
Kojima Y; Uchida K; Takiuchi H; Wakatsuki A; Sakurai T; Ochi S; Shirai D; Kobayashi Y
Hinyokika Kiyo; 1990 May; 36(5):587-91. PubMed ID: 2205088
[TBL] [Abstract][Full Text] [Related]
5. Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
Long HJ; Nelimark RA; Podratz KC; Suman V; Keeney GL; Nikcevich DA; Kugler JW; Rowland KM; Kardinal CG; Wos EJ
Gynecol Oncol; 2006 Mar; 100(3):501-5. PubMed ID: 16185755
[TBL] [Abstract][Full Text] [Related]
6. Cisplatin plus vinorelbine (PVn) as a salvage regimen for refractory breast cancer.
Chehal A; Taher A; Khalil M; Shamseddine A
Breast; 2004 Oct; 13(5):421-4. PubMed ID: 15454199
[TBL] [Abstract][Full Text] [Related]
7. Phase III trial of methotrexate, vinblastine, doxorubicin, and cisplatin versus carboplatin and paclitaxel in patients with advanced carcinoma of the urothelium.
Dreicer R; Manola J; Roth BJ; See WA; Kuross S; Edelman MJ; Hudes GR; Wilding G
Cancer; 2004 Apr; 100(8):1639-45. PubMed ID: 15073851
[TBL] [Abstract][Full Text] [Related]
8. Renal medullary carcinoma as an incidental finding in a horseshoe kidney: case report and literature review.
Molgat G; Afrouzian M; Trpkov K
Can J Urol; 2005 Oct; 12(5):2837-40. PubMed ID: 16274520
[TBL] [Abstract][Full Text] [Related]
9. [Outcome of treatment with surgical resection of the remaining tumor after modified M-VAC treatment for advanced urothelial carcinoma].
Narita S; Nakano M; Matsuzaki M; Watanabe J; Morikawa H; Murata H; Oda H; Komatsu H
Hinyokika Kiyo; 2005 Mar; 51(3):155-8. PubMed ID: 15852667
[TBL] [Abstract][Full Text] [Related]
10. [Chemotherapy of metastatic renal cell carcinoma with cis-diamminedichloroplatinum and other drugs].
Okumura S; Nishimura T; Yoshida K; Ohhara M; Hasegawa J; Hirasawa S; Hara M; Kawamura N; Kanamori S; Akimoto M
Hinyokika Kiyo; 1984 Sep; 30(9):1167-71. PubMed ID: 6084420
[TBL] [Abstract][Full Text] [Related]
11. [Bellini duct carcinoma of kidney with invasive growth pattern: a case report].
Jinza S; Asakura T; Takase K; Misaki H; Satomi Y; Nagashima Y
Hinyokika Kiyo; 1997 Apr; 43(4):291-4. PubMed ID: 9161859
[TBL] [Abstract][Full Text] [Related]
12. [Squamous cell carcinoma of the renal pelvis with elevation of G-CSF in the serum: a case report].
Fujii H; Nakamura T; Mikami K; Okihara K; Mizutani Y; Kawauchi A; Miki T
Hinyokika Kiyo; 2008 Nov; 54(11):733-6. PubMed ID: 19068728
[TBL] [Abstract][Full Text] [Related]
13. Cytologic features of renal medullary carcinoma.
Assad L; Resetkova E; Oliveira VL; Sun W; Stewart JM; Katz RL; Caraway NP
Cancer; 2005 Feb; 105(1):28-34. PubMed ID: 15593260
[TBL] [Abstract][Full Text] [Related]
14. Renal medullary carcinoma.
Baig MA; Lin YS; Rasheed J; Mittman N
J Natl Med Assoc; 2006 Jul; 98(7):1171-4. PubMed ID: 16895289
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
16. Response of metastatic renal medullary carcinoma to carboplatinum and Paclitaxel chemotherapy.
Gangireddy Vg; Liles GB; Sostre GD; Coleman T
Clin Genitourin Cancer; 2012 Jun; 10(2):134-9. PubMed ID: 22409864
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics of cisplatin and methotrexate after M-VAC chemotherapy for advanced urothelial cancer in hemodialysis patients.
Matsumoto K
Int J Urol; 2008 Oct; 15(10):949-50. PubMed ID: 19138292
[No Abstract] [Full Text] [Related]
18. [Pelvic lymph node metastasis from bladder cancer markedly responsive to methotrexate vinblastine doxorubicin and cisplatin (M-VAC) therapy followed by radiotherapy: a case report].
Hatano K; Kawashima A; Arai Y; Inoue H; Miyagawa Y; Takaha N; Nishimura K; Miyake O; Okuyama A
Hinyokika Kiyo; 2006 Oct; 52(10):801-3. PubMed ID: 17131872
[TBL] [Abstract][Full Text] [Related]
19. Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study.
Long HJ; Monk BJ; Huang HQ; Grendys EC; McMeekin DS; Sorosky J; Miller DS; Eaton LA; Fiorica JV;
Gynecol Oncol; 2006 Mar; 100(3):537-43. PubMed ID: 16216315
[TBL] [Abstract][Full Text] [Related]
20. Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium.
Yamada Y; Itoh Y; Aoki S; Nakamura K; Taki T; Naruse K; Tobiume M; Zennami K; Katsuda R; Kato Y; Watanabe M; Nishikawa G; Minami M; Nakahira M; Ukai S; Sawada M; Kitamura A; Honda N
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1079-83. PubMed ID: 19277660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
